EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chou, M. M.
Right arrow Articles by Buret, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chou, M. M.
Right arrow Articles by Buret, A. G.
Experimental Biology and Medicine 230:255-262 (2005)
© 2005 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Effects of Chondroitin and Glucosamine Sulfate in a Dietary Bar Formulation on Inflammation, Interleukin-1ß, Matrix Metalloprotease-9, and Cartilage Damage in Arthritis

May M. Chou*, Nathalie Vergnolle{dagger}, Jason J. McDougall{ddagger}, John L. Wallace{dagger}, Stephanie Marty{dagger}, Val Teskey§ and Andre G. Buret*,1

* Department of Biological Sciences, Faculty of Science, Mucosal Inflammation Research Group, {dagger} Department of Pharmacology and Therapeutics, Faculty of Medicine, Mucosal Inflammation Research Group, {ddagger} Department of Physiology and Biophysics, Faculty of Medicine, McCaig Centre for Joint Injury and Arthritis Research, University of Calgary, Calgary, Alberta, Canada, T2N 1N4; and § New Era Nutrition Inc., 10250-176 Street, Edmonton, Alberta, Canada, T5S 1L2

To whom requests for reprints should be addressed at 1 Department of Biological Sciences, University of Calgary, 2500 University Drive, Calgary, Alberta, Canada, T2N 1N4. E-mail: aburet{at}ucalgary.ca

This study examined the effects of chondroitin sulfate (CS) alone and CS plus glucosamine sulfate (GS) in a dietary bar formulation on inflammatory parameters of adjuvant-induced arthritis and on the synthesis of interleukin-1ß (IL-1ß) and matrix metalloprotease-9 (MMP-9). Following 25 days pretreatment with dietary bars containing either CS alone, CS plus GS, or neither CS nor GS, rats were either sham injected or injected with Freund’s complete adjuvant into the tail vein. Rats were fed their respective bars for another 17 days after inoculation. Parameters of disease examined included clinical score (combination of joint temperature, edema, hyperalgesia, and standing and walking limb function), incidence of disease, levels of IL-1ß in the serum and paw joints, levels of MMP-9 in the paw joints, paw joint histology, and joint cartilage thickness. Treatment with CS plus GS, but not CS alone, significantly reduced clinical scores, incidences of disease, joint temperatures, and joint and serum IL-1ß levels. Treatment with CS alone and CS plus GS inhibited the production of edema and prevented raised levels of joint MMP-9 associated with arthritis. Similarly, CS alone and CS plus GS treatment also prevented the development of cartilage damage associated with arthritis. Combination CS plus GS treatment in a dietary bar formulation ameliorates clinical, inflammatory, and histologic parameters of adjuvant-induced arthritis. The benefits of CS and GS in combination are more pronounced than those of CS alone. The reduction of arthritic disease by CS plus GS is associated with a reduction of IL-1ß and MMP-9 synthesis.

Key Words: chondroitin • glucosamine • MMP-9 • IL-1ß • cartilage




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
S. Sandya and P. R. Sudhakaran
Effect of Glycosaminoglycans on Matrix Metalloproteinases in Type II Collagen-Induced Experimental Arthritis
Experimental Biology and Medicine, May 1, 2007; 232(5): 629 - 637.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Experimental Biology and Medicine.